Bill summaries are authored by CRS.

Shown Here:
Passed House without amendment (10/01/2002)

Rare Diseases Orphan Product Development Act of 2002 - Amends the Orphan Drug Act to authorize appropriations for FY 2002 through 2006 for grants and contracts for the development of drugs for rare diseases and conditions.